• Future Pharma

Like other industries, the pharmaceutical industry had to make significant adjustments to both its operations and its selling strategies to address the disruptions caused by COVID-19. In-person sales and marketing consultations with physicians, long a staple of the industry, were no longer possible. As a result, many pharma companies shifted their marketing spending to digital. According to Accenture, 65% of meetings with pharma sales reps were held virtually during the pandemic.
Read more...